SRFSRF

₹2941.7-0.89%

Market Cap

₹87,166.68 Cr

Stock P/E

53.89

ROCE

12.35%

ROE

10.40%

Book Value

₹447.42

Financials

YoY Net Sales

EPS Growth

Operating Margin

No recent news available for this stock.

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

POSITIVES

•
Strong Q1 FY26 fundamentals with revenue, EBIT and PAT growth, plus an interim dividend signal.
•
Capex planned to support medium- to long-term demand, including agrochemical intermediates at Dahej.

NEGATIVES

•
Domestic market weakness and pricing pressures in fluorochemicals, with a tilt toward exports.
•
Quota regime for HFCs discussed as a complex topic requiring deeper explanation, indicating regulatory uncertainty.

Peer comparison data is not available for this stock.